EIF4EBP1 and mesothelioma: Furthermore, EIF4EBP1 acts as an oncogene in adenoid cystic carcinoma, bladder urothelial carcinoma, breast cancer (BRCA), KIRC, acute myeloid leukemia, liver hepatocellular carcinoma, lung adenocarcinoma, mesothelioma, and sarcoma.